BUSINESS
By NEW YORK TIMES NEWS SERVICE | January 12, 2006
The battle for control of Guidant Corp., a maker of implantable heart devices, took a new turn last night as Johnson & Johnson raised its bid to $23.2 billion and reached a new agreement with Guidant, pre-empting an offer from Boston Scientific. But outcome was quickly thrown into question when Boston Scientific dismissed Guidant's agreement saying: "Our discussions with Guidant are ongoing. We intend to vigorously pursue this transaction to its completion." Several people close to Boston Scientific suggested last night that the company was planning to make an offer higher than its original $25 billion.
BUSINESS
By Laura Pavlenko Lutton and Laura Pavlenko Lutton,MORNINGSTAR.COM | June 11, 2000
With many investors ducking for cover these days, there is a renewed interest in old, reliable companies such as consumer-products manufacturers. Shares of consumer-products companies tend to hold up better than the average stock during economic and stock-market downturns. After all, most consumers don't stop buying laundry detergent or Kleenex when the economy tanks, but they're probably less likely to buy high-technology or luxury products from the go-go growth companies. The best stocks among the consumer-product makers belong to firms with well-founded growth strategies.
NEWS
By New York Times News Service | May 14, 1991
CHICAGO -- Almost nine years after seven Chicago-area residents died from swallowing Tylenol capsules laced with cyanide, the manufacturer agreed yesterday to pay an undisclosed sum to the families of the victims just as the case was going to trial.Details of the settlement were sealed by Judge Warren Wolfson of Cook County Circuit Court, and neither the families' lawyers nor the company would say what form the compensation would take.But Bruce Pfaff, a lawyer for the plaintiffs, described the agreement as "a very favorable settlement for my clients."
SPORTS
By Jeff Zrebiec, The Baltimore Sun | May 16, 2013
Cut by the Ravens in early April, linebacker and special teams standout Brendon Ayanbadejo still hasn't ruled out playing in the NFL during the 2013 season. He works out daily and keeps himself ready in case a team calls and the situation is right. But right now, the 36-year-old is far too busy with other endeavors to be consumed with whether his 10-year NFL career is over. “There's not anything that I have to do right now so If the football angle has exhausted itself because there's no more options in football, then that will come to a close on its own and then there will be a point where I have to announce my retirement.
BUSINESS
By Andrew Leckey and Andrew Leckey,Tribune Media Services | March 25, 1992
Q. My family and I like buying stock in brand name products that we enjoy. We're considering buying shares of Wm. Wrigley Jr. Co., the chewing gum company. What are your thoughts?A. It remains a quality investment that sticks with you no matter what the economic conditions.However, don't buy shares of Wm. Wrigley Jr. Co. (around $71 a share, New York Stock Exchange) right now, even though current shareholders should hold on, advised Dick Elam, analyst with Blunt Ellis & Loewi Inc.The steady stocks in the packaged-food group, such as Wrigley, are most favored during recession.
NEWS
By Gazette, Colorado Springs | January 10, 1999
Hikers and skiers have a new piece of armor against the ravages of mangled skin.Johnson & Johnson has just released Band-Aid blister-relief cushions, designed to prevent hot spots from growing into blisters.The rubber-like adhesive pads mold to the body. They provide a cushion against rubbing shoes. They are slightly thinner than moleskin, but unlike that old standby, they hold moisture in the skin to speed healing.